FDA Inspection 1247827 — Howard J. Rubenstein, MD
The FDA completed an inspection of Howard J. Rubenstein, MD on August 22, 2024 in Saraland, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 22, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saraland, AL (United States)
Additional Details
Clinical Investigator (CI)